Connection
Mary Weiser-Evans to Pyrimidinones
This is a "connection" page, showing publications Mary Weiser-Evans has written about Pyrimidinones.
|
|
Connection Strength |
|
 |
|
 |
|
0.042 |
|
|
|
-
Brown CN, Atwood DJ, Pokhrel D, Ravichandran K, Holditch SJ, Saxena S, Miyazaki M, Nemenoff R, Weiser-Evans MCM, Ljubanovic DG, Joy MS, Edelstein CL. The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in mice. Cell Signal. 2020 07; 71:109605.
Score: 0.042